Symbiox Investme — 360° view

Symbiox Investme, a company in the Other Financial Services industry, reported revenue of ₹0.42 crore and net profit of ₹0.05 crore for the September 2026 quarter.

Symbiox Investme (BSE: SYMBIOX) closed at ₹1.61 on 20 Nov 2026, down 45.4% over the past year. Its market capitalisation is ₹5 crore and it trades at 33.6 times earnings.

Share price
₹1.61 (20 Nov 2026)
Market cap
₹5 Cr (20 Nov 2026)
P/E
33.60 (20 Nov 2026)
Revenue
₹0 Cr (September 2026 quarter)
Net profit
₹0 Cr (September 2026 quarter)
ROCE
0.66% (FY26)
ROE
0.47% (FY26)
Book value
₹10.2 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹3.00 / ₹1.36 (20 Nov 2026)
1-year return
-45.4% (to 20 Nov 2026)
Sector
Financial Services
Industry
Other Financial Services
Symbol
BSE: SYMBIOX

Incorporated in 1979, Symbiox Investment & Trading Company Ltd is mainly into Trading in textile goods, and Loans & Investments.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.